Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-23

Clinical Trial Update: Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon

View source ↗

Summary

A follow-up clinical trial involving Rituximab and alpha interferon for follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon Alfa (interferon alfa)
  • Rituximab (rituximab)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Lymphoma, Follicular | Status: COMPLETED